SDH
Sloy Dahl & Holst’s ARK Genomic Revolution ETF ARKG Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-12,465
| Closed | -$319K | – | 110 |
|
|
2024
Q3 | $319K | Sell |
12,465
-2,508
| -17% | -$64.2K | 0.05% | 73 |
|
|
2024
Q2 | $352K | Buy |
14,973
+1,723
| +13% | +$40.5K | 0.07% | 62 |
|
|
2024
Q1 | $381K | Sell |
13,250
-242
| -2% | -$6.96K | 0.09% | 58 |
|
|
2023
Q4 | $443K | Buy |
13,492
+2,079
| +18% | +$68.2K | 0.09% | 54 |
|
|
2023
Q3 | $318K | Buy |
11,413
+1,131
| +11% | +$31.5K | 0.07% | 61 |
|
|
2023
Q2 | $351K | Sell |
10,282
-215
| -2% | -$7.33K | 0.06% | 56 |
|
|
2023
Q1 | $316K | Buy |
10,497
+175
| +2% | +$5.26K | 0.07% | 48 |
|
|
2022
Q4 | $291K | Sell |
10,322
-1,349
| -12% | -$38.1K | 0.1% | 50 |
|
|
2022
Q3 | $384K | Buy |
11,671
+1,379
| +13% | +$45.4K | 0.08% | 49 |
|
|
2022
Q2 | $324K | Buy |
10,292
+1,761
| +21% | +$55.4K | 0.08% | 52 |
|
|
2022
Q1 | $392K | Buy |
8,531
+26
| +0.3% | +$1.2K | 0.07% | 48 |
|
|
2021
Q4 | $635K | Hold |
8,505
| – | – | 0.14% | 40 |
|
|
2021
Q3 | $635K | Sell |
8,505
-1,421,578
| -99% | -$106M | 0.14% | 40 |
|
|
2021
Q2 | $132M | Buy |
1,430,083
+70,915
| +5% | +$6.56M | 17.79% | 3 |
|
|
2021
Q1 | $121M | Buy |
+1,359,168
| New | +$121M | 17.25% | 3 |
|